RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,014 | -39.7% | 10,183 | -6.9% | 0.00% | – |
| Q4 2022 | $38,160 | -96.6% | 10,934 | -63.8% | 0.00% | -100.0% |
| Q3 2022 | $1,117,000 | +106.5% | 30,171 | +5.8% | 0.00% | +100.0% |
| Q2 2022 | $541,000 | -35.8% | 28,507 | -8.7% | 0.00% | 0.0% |
| Q1 2022 | $843,000 | +31.9% | 31,222 | +10.1% | 0.00% | 0.0% |
| Q4 2021 | $639,000 | +38.0% | 28,366 | +60.7% | 0.00% | 0.0% |
| Q3 2021 | $463,000 | -30.2% | 17,656 | -14.8% | 0.00% | 0.0% |
| Q2 2021 | $663,000 | -14.8% | 20,724 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $778,000 | +9.6% | 22,104 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $710,000 | -13.5% | 22,130 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $821,000 | -13.5% | 21,832 | +3.0% | 0.00% | -50.0% |
| Q2 2020 | $949,000 | – | 21,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |